Companies → Moderna, Inc.
Moderna, Inc.
United States, Massachusetts, Cambridge
Updated Jul 18, 2024 10:29
Description
Moderna is a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines to improve the lives of patients. It has transformed from a research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across six modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for both clinical and commercial production at scale. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators. The US accounts for about 35% of revenue.
Address:
200 Technology Sq Cambridge
MA
02139-3578 United States
Website:
Revenue
$6850M
Company is likely to buy
- Messenger rna (mrna) therapeutics
- Lipid nanoparticle formulation
- Therapeutics
- Intellectual property portfolio
- Integrated manufacturing plant
- Alliances with government collaborators
- Alliances with commercial collaborators
- Research-stage programs
- Pharmaceutical preparations
- Chemicals and allied products
- Manufacturing plant
- Commercial production
- Scale production
- Domestic alliances
- Overseas alliances
- Government collaborators
- Commercial collaborators
- Revenue generation
- Biotechnology products
- Transformative medicines
- Patient improvement
- Clinical trials
- Healthcare advancements
- Medical breakthroughs
- Innovative therapies
- Life-saving treatments
- Disease prevention
- Vaccines
- Clinical portfolio of vaccines
Company is likely to sell
- Messenger rna (mrna) therapeutics
- Lipid nanoparticle formulation
- Therapeutics
- Intellectual property portfolio
- Integrated manufacturing plant
- Alliances with government collaborators
- Alliances with commercial collaborators
- Research-stage programs
- Pharmaceutical preparations
- Chemicals and allied products
- Manufacturing plant
- Commercial production
- Scale production
- Domestic alliances
- Overseas alliances
- Government collaborators
- Commercial collaborators
- Revenue generation
- Biotechnology products
- Transformative medicines
- Patient improvement products
- Clinical trials
- Healthcare innovations
- Medical breakthroughs
- Life-saving treatments
- Disease prevention products
- Innovative therapies
- Vaccines
- Clinical portfolio of vaccines
Disclaimer:
IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.